RecruitingPHASE1, PHASE2NCT05918640

Lurbinectedin in FET-Fused Tumors

Studying Desmoplastic small round cell tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Theodore Laetsch, MD
Children's Hospital of Philadelphia
Intervention
Lurbinectedin(drug)
Enrollment
63 enrolled
Eligibility
10 years · All sexes
Timeline
20232028

Study locations (6)

Collaborators

Jazz Pharmaceuticals · Stand Up To Cancer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05918640 on ClinicalTrials.gov

Other trials for Desmoplastic small round cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoplastic small round cell tumor

← Back to all trials